Details for Patent: 6,858,584
✉ Email this page to a colleague
Title: | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
Abstract: | Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions. |
Inventor(s): | Judice; J. Kevin (El Granada, CA), Shaw; Jeng-Pyng (Saratoga, CA), Mu; YongQi (Los Altos, CA), Conner; Michael W. (Half Moon Bay, CA), Pace; John L. (San Anselma, CA) |
Assignee: | Theravance, Inc. (South San Francisco, CA) |
Filing Date: | May 01, 2001 |
Application Number: | 09/846,893 |
Claims: | 1. A pharmaceutical composition comprising: (a) a cyclodextrin; and (b) a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof. 2. The pharmaceutical composition of claim 1 which further comprises water. 3. The pharmaceutical composition of claim 1 which is a powder. 4. The pharmaceutical composition of claim 1 which is a lyophilized powder. 5. A pharmaceutical composition comprising: (a) an aqueous cyclodextrin carrier and (b) a therapeutically effective amount of a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof. 6. The pharmaceutical composition of claim 5, wherein the pharmaceutical composition comprises: (a) a therapeutically effective amount of a lipidated glycopeptide antibiotic or a pharmaceutically acceptable salt thereof; (b) 1 to 40 weight percent of a cyclodextrin; and (c) 60 to 99 weight percent of water based on 100 weight percent of the composition. 7. The pharmaceutical composition of claim 5, wherein the cyclodextrin is hydroxypropyl-.beta.-cyclodextrin or sulfobutyl ether .beta.-cyclodextrin. 8. The pharmaceutical composition of claim 7, wherein the cyclodextrin is hydroxypropyl-.beta.-cyclodextrin. 9. The pharmaceutical composition of claim 6, wherein the cyclodextrin comprises about 5 to 35 weight percent of the composition. 10. The pharmaceutical composition of claim 9, wherein the cyclodextrin comprises about 10 to 30 weight percent of the composition. |